Skip to main content

Advertisement

Log in

Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients

  • Original Article
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Subependymal giant cell astrocytomas (SEGA) are benign tumors characteristic of tuberous sclerosis complex (TSC) that may cause hydrocephalus. Various treatments are nowadays available as mTOR inhibitors or surgery. Surgery is still a valid option especially for symptomatic and larger tumors.

Methods

From January 1994 to December 2015, 31 TSC patients harboring SEGA underwent surgery at the Department of Neurosurgery of the Meyer Pediatric Hospital, Florence. Indications for surgery were tumor size and location, growth and cystization/hemorrhage, and hydrocephalus. Clinical data, preoperative and postoperative MRI, recurrence rate, further surgical procedures, and related complications were analyzed.

Results

A total of 44 surgeries were performed in 31 TSC patients affected by SEGA, achieving gross total removal (GTR) and subtotal removal (STR), respectively, in 36 and 8 patients. Recurrences occurred in 11 patients; 9 of them underwent further surgical procedures and 2 were treated with mTOR pathway inhibitors. Surgical morbidity and mortality were, respectively, 22.7% and 2.3%. After a mean follow-up of 4.9 years, 90% of patients were tumor-free with good neurological status in 93.3%; twelve (40%) had a ventriculo-peritoneal shunt (VPS) for hydrocephalus.

Conclusions

The present series confirms that the surgical approach, combined with mTOR inhibitors, is still a valid option for the treatment of SEGAs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ (1997) Identification of the tuberous sclerosis gene TSC1 on chromosme 9q34. Science 277:805–808

    Article  Google Scholar 

  2. Rieger E, Kerl H (1992) The clinical spectrum of organ manifestations of tuberous sclerosis. Hautarzt. 43(5):272

    CAS  PubMed  Google Scholar 

  3. Bourneville DM (1880) Sclérose tubéreuse des circonvolutions cérébrales: idiote et épilepsie hémiplégique. Arhc Neurol 1:81–91

    Google Scholar 

  4. Nagib MG, Haines SJ, Erickson DL, Mastri AR (1984) Tuberous sclerosis: a review for the neurosurgeon. Neurosurgery 14(1):93–98

    Article  CAS  Google Scholar 

  5. O’Callaghan FJK, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP (2008) Subependymal nodules, giant-cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 93:751–754

    Article  Google Scholar 

  6. Curatolo P, Jozwiak S, Nabbout R (2012) Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendation. Eur J Paediatr Neurol 16(6):582–586

    Article  Google Scholar 

  7. Feliciano DM, Lin TV, Hartman NW, Bartley CM, Kubera C, Hsieh L, Lafourcade C, O'Keefe RA, Bordey A (2013) A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Int J Dev Neurosci 31(7):667–678

    Article  CAS  Google Scholar 

  8. Harter DH, Bassani L, Rodgers SD, Roth J, Devinski O, Carlson C, Wisoff JH, Weiner HL (2014) A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatrics 13:21–28

    Article  Google Scholar 

  9. Frerebau P, Benezech J, Segnarbieux F, Harbi H, Desy A, Marty-Double C (1985) Intraventricular tumors in tuberous sclerosis. Childs Nerv Syst 1:45–48

    Article  Google Scholar 

  10. McLaurin RL, Towbin RB (1985) Tuberous sclerosis: diagnostic and surgical considerations. Pediatr Neurosci 12:43–48

    Article  Google Scholar 

  11. Sinson G, Sutton LN, Yachnis AT, Duhaime AC, Schut I (1994) Subependymal giant cell astrocytomas in children. Pediatr Neurosurg 20:233–239

    Article  CAS  Google Scholar 

  12. Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C (1999) Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 66(3):370–375

    Article  CAS  Google Scholar 

  13. de Ribaupierre S, Vernet O, Vinchon M, Rilliet B (2008) Phacomatoses et tumeurs génétiquement déterminées: la transition enfant-adulte. Neurochirurgie 54:642–653

    Article  Google Scholar 

  14. Katz JS, Milla SS, Wiggins GC, Devinsky O, Weiner HL, Roth J (2012) Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus. J Neurosurg Pediatrics 9:406–413

    Article  Google Scholar 

  15. Kim SK, Wang KC, Cho BK, Jung HW, Lee YJ, Chung YS, Lee JY, Park SH, Kim YM, Choe G, Chi JG (2001) Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. J Neuro-Oncol 52:217–225

    Article  CAS  Google Scholar 

  16. Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461

    Article  Google Scholar 

  17. Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66(8):792–796

    Article  CAS  Google Scholar 

  18. Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, Chen J (2014) Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst 30:561–570

    Article  Google Scholar 

  19. Holanda FJ, Holanda GM (2004) Tuberous sclerosis. Neurosurgical indications in intraventricular tumors. Neurosurg Rev 63:1457–1461

    Google Scholar 

  20. de Ribaupierre S, Dorfmuller G, Bulteau C, Fohlen M, Pinard JM, Chiron C, Delalande O (2007) Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate. Neurosurgery 60:83–90

    Article  Google Scholar 

  21. Cuccia V, Zuccaro G, Sosa F, Monges J, Lubieniekey F, Taratuto AL (2003) Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst 19:232–243

    Article  Google Scholar 

  22. Kumar R, Singh V (2004) Subependymal giant cell astrocytoma: a report of five cases. Neurosurg Rev 27:274–280

    PubMed  Google Scholar 

  23. Genitori L, Donati P, Giordano F, Mussa F, Sanzo M, Sardo L, Spacca B, Di Pietro G, Shamsaldin M, Oliveri G (2006) Neurosurgical strategies in the management of subependymal giant cell tumors in tuberous sclerosis complex. Neurocutaneous syndromes in children. In: Curatolo P, Riva D (eds) Chapter 11. John Libbey Eurotext, Montrouge, France. pp 117–138.

  24. Cai R, Di X (2010) Combined intra- and extra-endoscopic techniques for aggressive resection of subependymal Giant cell Astrocytomas. World Neurosurg 73(6):713–718

    Article  Google Scholar 

  25. Roszkowski M, Drabik K, Barszcz S, Jowziak S (1995) Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Childs Nerv Syst 11:335–339

    Article  CAS  Google Scholar 

  26. Turgut M, Akalan N, Ozgen T, Ruacan S, Erbengi A (1996) Subependymal giant cell astrocytoma associated with tuberous sclerosis: diagnostic and surgical characteristics of five cases with unusual features. Clin Neurol Neurosurg 98:217–221

    Article  CAS  Google Scholar 

  27. Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Viano J, Carceller F, Hernandez-Moneo JL, Gutierrez-Molina M, Morales C (2010) Subependymal giant-cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients. Neurologia 25(5):314–321

    Article  CAS  Google Scholar 

  28. Jiang T, Jia G, Ma ZY, Luo SQ, Zhang YQ (2011) The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis. Childs Nerv Syst 27:55–62

    Article  CAS  Google Scholar 

  29. Moavero R, Pinci M, Bombardieri R, Curatolo P (2011) The management of subependymal giant-cell tumors in tuberous sclerosis: a clinician’s perspective. Childs Nerv Syst 27:1203–1210

    Article  Google Scholar 

  30. Pascual-Castroviejo I (2011) Neurosurgical treatment of tuberous sclerosis complex lesions. Childs Nerv Syst 27:1211–1219

    Article  Google Scholar 

  31. Rodgers SD, Bassani L, Weiner HL, Harter DH (2012) Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma. J Neurosurg Pediatrics 9:417–420

    Article  Google Scholar 

  32. Amin S, Carter M, Edwards RJ, Pople I, Aquilina K, Merrifield J, Osborne JP, O’Callaghan FJK (2013) The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex. Eur J Paediatr Neurol 17:36–44

    Article  Google Scholar 

  33. Jozwiak S, Nabbout R, Curatolo P (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) patients: clinical recommendations. Eur J Paediatr Neurol 17:348–352

    Article  Google Scholar 

  34. Roth J, Roach ES, Bartels U, Jozwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ (2013) Subependymal Giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012. Pediatr Neurol 49:439–444

    Article  Google Scholar 

  35. Kotulska K, Borkowska J, Roszkowski M, Mandera M, Dasziewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domanska-Pakiela D, Jozwiak S (2014) Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol 50:307–312

    Article  Google Scholar 

  36. Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S (2013) Efficacy and safety of Everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multi-center, randomized, placebo-controlled phase 3 trial. Lancet 381(9861):125–132

    Article  CAS  Google Scholar 

  37. di Rocco C, Iannelli A, Marchese E (1995) On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis. Pediatr Neurosurg 23(3):115–121

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Flavio Giordano.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giordano, F., Moscheo, C., Lenge, M. et al. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients. Childs Nerv Syst 36, 951–960 (2020). https://doi.org/10.1007/s00381-019-04449-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-019-04449-w

Keywords

Navigation